---
title: "Cinnarizine - Vertigo - 2"
sidebar: mydoc_sidebar
permalink: db00568-mesh-d014717-2.html
toc: false 
---


Path ID: `DB00568_MESH_D014717_2`
{% include image.html url="images/db00568-mesh-d014717-2.png" file="db00568-mesh-d014717-2.png" alt="db00568-mesh-d014717-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D002936 | cinnarizine | Drug |
| UniProt:Q9P0X4 | T-type calcium channel | Protein |
| GO:0014829 | vascular smooth muscle contraction | BiologicalProcess |
| MESH:D014717 | vertigo | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Cinnarizine | DECREASES ACTIVITY OF | T-Type Calcium Channel |
| T-Type Calcium Channel | NEGATIVELY REGULATES | Vascular Smooth Muscle Contraction |
| Vascular Smooth Muscle Contraction | TREATS | Vertigo |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00568#mechanismofaction](https://go.drugbank.com/drugs/DB00568#mechanismofaction)
